PTC Therapeutics, Inc.  announced today that it has withdrawn the New Drug Application (NDA) resubmission for Translarnatm (ataluren) for the treatment of nonsense mutation Duchenne muscular dystrophy ...

PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today that it has withdrawn the New Drug Application (NDA) resubmission for Translarna™ (ataluren) for the treatment of nonsense mutation Duchenne ...

Orna Therapeutics, which engineers immune cells inside the body, will fold into one of the world’s largest drugmakers. The ...

Prenatal exposure to PPIs and H2 receptor antagonists were not found to increase risk for neuropsychiatric disorders in offspring.

Our current approach to mental health labelling and diagnosis has brought benefits. But as a practising doctor, I am concerned that it may be doing more harm than good ...

Palatin Technologies, Inc. , a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor (MCR) system, today announced ...

Inside the lab where scientists want to rewrite our DNA from scratch - Artificial biological intelligence could change ...

Advancing differentiated MC4R-based obesity programs into clinical development Melanocortin-based obesity therapies targeting rare MC4R pathway disorders with a primary ...

PBS NC helps your community explore new worlds and ideas through programs that educate, inform and inspire. Your ...

Following a landmark ruling affirming the validity of Research and Development (R&D) credit claims for crop producers, the U.S. Tax Court has now confirmed that innovations in livestock production ...

The Odessa American is the leading source of local news, information, entertainment and sports for the Permian Basin.

The registrations for NEET 2026 have commenced. In order to appear for the MBBS entrance test, the candidates need to be well aware of the syllabus for the test. The National ...